ArticleImmunity2020

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.

Xiancai Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.